Literature DB >> 28017959

Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells.

Ralf Weiskirchen1, Frank Tacke2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28017959      PMCID： PMC5301158          DOI： 10.1038/cmi.2016.62

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  19 in total

Review 1.  Immunology in the liver--from homeostasis to disease.

Authors:  Felix Heymann; Frank Tacke
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-01-13       Impact factor: 46.802

2.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

Authors:  Jochen Schmitz; Alexander Owyang; Elizabeth Oldham; Yaoli Song; Erin Murphy; Terril K McClanahan; Gerard Zurawski; Mehrdad Moshrefi; Jinzhong Qin; Xiaoxia Li; Daniel M Gorman; J Fernando Bazan; Robert A Kastelein
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

3.  Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice.

Authors:  Nozomu Sakai; Heather L Van Sweringen; R Cutler Quillin; Rebecca Schuster; John Blanchard; Justin M Burns; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

Review 4.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

5.  Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.

Authors:  Gregory Noel; Muhammad Imran Arshad; Aveline Filliol; Valentine Genet; Michel Rauch; Catherine Lucas-Clerc; Agnès Lehuen; Jean-Philippe Girard; Claire Piquet-Pellorce; Michel Samson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-06-23       Impact factor: 4.052

6.  Structural insights into the interaction of IL-33 with its receptors.

Authors:  Xi Liu; Michal Hammel; Yanfeng He; John A Tainer; U-Ser Jeng; Linqi Zhang; Shuying Wang; Xinquan Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

7.  Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis.

Authors:  Kevin M Vannella; Thirumalai R Ramalingam; Lee A Borthwick; Luke Barron; Kevin M Hart; Robert W Thompson; Kristen N Kindrachuk; Allen W Cheever; Sandra White; Alison L Budelsky; Michael R Comeau; Dirk E Smith; Thomas A Wynn
Journal:  Sci Transl Med       Date:  2016-05-04       Impact factor: 17.956

8.  High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma.

Authors:  Dominik Bergis; Valentin Kassis; Annika Ranglack; Verena Koeberle; Albrecht Piiper; Bernd Kronenberger; Stefan Zeuzem; Oliver Waidmann; Heinfried H Radeke
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

9.  Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure.

Authors:  Ziying Lei; Zhishuo Mo; Jianyun Zhu; Xiuqing Pang; Xingrong Zheng; Zhebin Wu; Ke Wang; Xinhua Li; Dongying Xie; Zhiliang Gao
Journal:  Mediators Inflamm       Date:  2015-03-29       Impact factor: 4.711

Review 10.  Interleukins in chronic liver disease: lessons learned from experimental mouse models.

Authors:  Linda Hammerich; Frank Tacke
Journal:  Clin Exp Gastroenterol       Date:  2014-09-01
View more
  17 in total

1.  Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic type 2 inflammation.

Authors:  Zhixuan Loh; Rebecca L Fitzsimmons; Robert C Reid; Divya Ramnath; Andrew Clouston; Praveer K Gupta; Katharine M Irvine; Elizabeth E Powell; Kate Schroder; Jennifer L Stow; Matthew J Sweet; David P Fairlie; Abishek Iyer
Journal:  Br J Pharmacol       Date:  2019-08-17       Impact factor: 8.739

Review 2.  IL-33/ST2 Axis in Organ Fibrosis.

Authors:  Ourania S Kotsiou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

Review 3.  IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies.

Authors:  Andreea-Manuela Mirea; Cees J Tack; Triantafyllos Chavakis; Leo A B Joosten; Erik J M Toonen
Journal:  Trends Mol Med       Date:  2018-04-14       Impact factor: 11.951

4.  Interleukin-33 Exacerbates IgA Glomerulonephritis in Transgenic Mice Overexpressing B Cell Activating Factor.

Authors:  Yuan Min Wang; Karli Shaw; Geoff Yu Zhang; Edmund Y M Chung; Min Hu; Qi Cao; Yiping Wang; Guoping Zheng; Huiling Wu; Steven J Chadban; Hugh J McCarthy; David C H Harris; Fabienne Mackay; Shane T Grey; Stephen I Alexander
Journal:  J Am Soc Nephrol       Date:  2022-04-06       Impact factor: 14.978

5.  Enhanced activation of human NK cells by drug-exposed hepatocytes.

Authors:  Frank Fasbender; Martin Obholzer; Sarah Metzler; Regina Stöber; Jan G Hengstler; Carsten Watzl
Journal:  Arch Toxicol       Date:  2020-02-14       Impact factor: 5.153

6.  Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease.

Authors:  Andrew Rasky; David M Habiel; Susan Morris; Matthew Schaller; Bethany B Moore; Sem Phan; Steven L Kunkel; Martin Phillips; Cory Hogaboam; Nicholas W Lukacs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-20       Impact factor: 5.464

7.  The effects of interleukin-33 on airways collagen deposition and matrix metalloproteinase expression in a murine surrogate of asthma.

Authors:  Gao An; Xin Zhang; Wenjun Wang; Qiong Huang; Yan Li; Shan Shan; Chris J Corrigan; Wei Wang; Sun Ying
Journal:  Immunology       Date:  2018-02-18       Impact factor: 7.397

8.  Disulfiram Treatment Normalizes Body Weight in Obese Mice.

Authors:  Michel Bernier; Sarah J Mitchell; Devin Wahl; Antonio Diaz; Abhishek Singh; Wonhyo Seo; Mingy Wang; Ahmed Ali; Tamzin Kaiser; Nathan L Price; Miguel A Aon; Eun-Young Kim; Michael A Petr; Huan Cai; Alessa Warren; Clara Di Germanio; Andrea Di Francesco; Ken Fishbein; Vince Guiterrez; Dylan Harney; Yen Chin Koay; John Mach; Ignacio Navas Enamorado; Tamara Pulpitel; Yushi Wang; Jing Zhang; Li Zhang; Richard G Spencer; Kevin G Becker; Josephine M Egan; Edward G Lakatta; John O'Sullivan; Mark Larance; David G LeCouteur; Victoria C Cogger; Bin Gao; Carlos Fernandez-Hernando; Ana Maria Cuervo; Rafael de Cabo
Journal:  Cell Metab       Date:  2020-05-14       Impact factor: 27.287

Review 9.  IL-33-ST2 Axis in Liver Disease: Progression and Challenge.

Authors:  Zijian Sun; Binxia Chang; Miaomiao Gao; Jiyuan Zhang; Zhengsheng Zou
Journal:  Mediators Inflamm       Date:  2017-10-18       Impact factor: 4.711

Review 10.  The Roles of Liver-Resident Lymphocytes in Liver Diseases.

Authors:  Yanan Wang; Cai Zhang
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.